Authors and Disclosures
M.T. Khan1–4, M. O'Sullivan5,6, B. Faitli1, J.E. Mellerio1,7,8, R. Fawkes8, M. Wood1, L.D. Hubbard7, A.G. Harris3,9, L. Iacobaccio10, T. Vlahovic11, L. James5,6, L. Brains12, M. Fitzpatrick12,13 and K. Mayre-Chilton7,13
1EB Department, Great Ormond Street Hospital for Sick Children, London, U.K.
2Royal London Hospital for Integrated Medicine, UCLH, London, U.K.
3St George Hospital, Sydney, NSW, Australia
4Barts and The London NHS Foundation Trust, London, U.K.
5University Hospitals Birmingham NHS Trust, Solihull Hospital, Solihull, U.K.
6Birmingham Women's and Children's NHS Foundation Trust, Podiatry Birmingham, Birmingham, U.K.
7St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, U.K.
8St John's Institute of Dermatology, Rare Diseases Centre, London, U.K.
9Department of Dermatology, Concord Hospital, Sydney, NSW, Australia
10The Royal Melbourne Hospital, Melbourne, VIC, Australia
11Temple University, Philadelphia, PA, U.S.A.
12DEBRA Australia Member and Volunteer, Pittsworth, QLD, Australia
13DEBRA International, Vienna, Austria
Mohammed Tariq Khan. E-mail: email@example.com
Conflicts of interest
Marigold Footcare Limited is family owned by one author (M.T.K.); however, M.T.K. does not have any financial interests and acts as a company consultant on an honorary basis. M.T.K., R.F. and M.W. are consultants for a project called REBOOT but have no financial interests in any shoe supplier or distributor; and K.M.-C. is an associate to DEBRA International. M.W. and K.M.-C. were therefore not involved in the final editions of the recommendation manuscript, editions post-review or panel feedback. The reviewers declared no potential conflicts of interest with respect to the publication of this guideline.